Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.08) per share. This is a 119.05 percent decrease over earnings of $0.42 per share from the same period last year.
For now, Tesla has avoided a major setback, but the days ahead will reveal whether the company's direction is sufficient to engineer a fundamental turnaround.